FitLife Brands Announces its Participation at the 37th Annual Roth Conference and Provides Financial and Operational Update
MWN-AI** Summary
FitLife Brands, Inc. (Nasdaq: FTLF), a prominent provider of nutritional supplements and wellness products, announced its participation in the 37th Annual Roth Conference scheduled for March 17-18, 2025. The event is an opportunity for investors to engage with FitLife management. Interested parties are encouraged to coordinate meetings through Roth representatives. Ahead of the conference, FitLife will file an updated investor presentation with the Securities and Exchange Commission (SEC) while also preparing for the financial performance report for the fourth quarter and full-year 2024, which is set to be released on March 27, 2025.
In its preliminary operational update, FitLife forecasts a net revenue range of $64-65 million for full-year 2024, marking an increase of approximately 21-23% from 2023. The Company also anticipates an adjusted EBITDA of between $14.0-14.2 million, a growth of 38-40% year-over-year. Additionally, a projected net income ranging from $8.9-9.1 million signifies a substantial increase of 68-72% compared to the prior year.
As of December 31, 2024, FitLife had a term loan outstanding of $13.1 million, with no balance on its revolving credit facility and a cash reserve of $4.5 million. The total shares outstanding as of March 12, 2025, were reported at 9,218,528.
FitLife Brands is dedicated to developing and marketing over 250 innovative products, mainly sold online and through GNC® franchises, as well as various retail outlets. While the outlook appears positive, the Company cautioned about inherent risks that could impact its future performance, encouraging stakeholders to review these uncertainties in its SEC filings. For more details, visit FitLife's website at www.fitlifebrands.com.
MWN-AI** Analysis
FitLife Brands, Inc. (Nasdaq: FTLF) has recently announced its participation in the 37th Annual Roth Conference, coupled with a financial and operational update, which presents an intriguing opportunity for investors. As the company gears up for this significant investment forum, it anticipates a robust performance in 2024, with expected net revenues between $64 million to $65 million, indicating a growth of 21-23% from the previous year. This growth trajectory is further supported by a forecasted Adjusted EBITDA of $14.0 million to $14.2 million, reflecting an impressive 38-40% increase year over year.
Investors should take note of the anticipated net income of approximately $9 million, which suggests a 68-72% growth. This demonstrates FitLife’s capability to expand its profitability in a competitive market environment, bolstered by strong consumer demand for wellness products. With a current cash reserve of $4.5 million and a manageable $13.1 million outstanding on its term loan, the company appears well-positioned to sustain its operational efficacy into the next fiscal year.
As FitLife plans to provide more detailed insights through its forthcoming 10-K filing on March 27, 2025, investor sentiment may be buoyed by the upcoming disclosures. Potential investors should consider the company’s comprehensive approach to product development and marketing as it leverages both online platforms and retail partnerships to reach health-conscious consumers.
However, caution is warranted due to the inherent market uncertainties outlined in their forward-looking statements. While the growth estimates are promising, the company faces challenges typical of the nutritional supplement sector. As such, investors should weigh FitLife's strategic growth initiatives against potential market volatility when making investment decisions, particularly following the insights shared at the Roth Conference.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Omaha, NE, March 13, 2025 (GLOBE NEWSWIRE) -- FitLife Brands, Inc. (“FitLife,” or the “Company”) (Nasdaq: FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced that it will participate in the 37 th Annual Roth Conference on Monday and Tuesday, March 17-18, 2025. Investors who are interested in meeting with FitLife management should submit their requests through their Roth representative.
In conjunction with its participation in the conference, the Company has prepared an updated investor presentation which will be filed with the Securities and Exchange Commission on Form 8-K in advance of the conference.
The Company plans to report its financial performance for the fourth quarter and full year of 2024 with the Securities and Exchange Commission on Form 10-K on March 27, 2025. However, in order to facilitate upcoming investor discussions, the Company is providing the following financial and operational update regarding the Company’s recent performance:
- Net revenue for the full year 2024 is anticipated to be between $64-65 million, an increase of 21-23% compared to 2023.
- Adjusted EBITDA for the full year 2024 is anticipated to be between $14.0-14.2 million, an increase of 38-40% compared to 2023.
- Net income for the full year 2024 is anticipated to be between $8.9-9.1 million, an increase of 68-72% compared to 2023.
- As of December 31 st , 2024, the Company had $13.1 million outstanding on its term loan and no balance outstanding on its revolver.
- As of December 31 st , 2024, the Company had $4.5 million of cash.
- Shares outstanding as of March 12, 2025 were 9,218,528.
About FitLife Brands
FitLife Brands is a developer and marketer of innovative and proprietary nutritional supplements and wellness products for health-conscious consumers. FitLife markets more than 250 different products primarily online, but also through domestic and international GNC® franchise locations as well as through various other retail locations. FitLife is headquartered in Omaha, Nebraska. For more information, please visit our website at www.fitlifebrands.com .
Forward-Looking Statements
Statements in this release that are forward-looking involve known and unknown risks and uncertainties, which may cause the Company's actual results in future periods to be materially different from any future performance that may be suggested in this news release. Such factors may include, but are not limited to, the ability of the Company to continue to grow revenue, and the Company's ability to continue to achieve positive cash flow given the Company's existing and anticipated operating and other costs. Many of these risks and uncertainties are beyond the Company's control. Reference is made to the discussion of risk factors detailed in the Company's filings with the Securities and Exchange Commission including its reports on Form 10-K and 10-Q. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the dates on which they are made.
Non-GAAP Financial Measures
This press release contains certain financial measures defined as “non-GAAP financial measures” by the SEC, including non-GAAP adjusted EBITDA. These measures may be different from non-GAAP financial measures used by other companies. The presentation of this financial information, which is not prepared under any comprehensive set of accounting rules or principles, is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP.
As presented herein, non-GAAP EBITDA excludes interest, foreign exchange gains and losses, income taxes, and depreciation and amortization. Adjusted non-GAAP EBITDA excludes, in addition to interest, foreign exchange gains and losses, taxes, depreciation and amortization, equity-based compensation, M&A/integration activities, and non-recurring gains or losses. The Company believes the non-GAAP measures provide useful information to both management and investors by excluding certain expenses and other items that may not be indicative of its core operating results and business outlook. The Company believes that the inclusion of non-GAAP measures in the financial presentation herein allows investors to compare the Company’s financial results with the Company’s historical financial results and is an important measure of the Company’s comparative financial performance.
investor@fitlifebrands.com
FAQ**
How does FitLife Brands Inc. (FTLF) plan to sustain its impressive revenue growth of 21-23% from 2023 to 2024, and what specific strategies will be highlighted during the upcoming Roth Conference?
Can you provide insights into how FitLife Brands Inc. (FTLF) intends to improve its adjusted EBITDA to an estimated $14.0-14.2 million in 20despite market challenges?
With a significant net income increase projected for 2024, what factors does FitLife Brands Inc. (FTLF) attribute to this growth, and how will it support future investments in product development?
Given the reported $13.1 million owed on the term loan, how is FitLife Brands Inc. (FTLF) managing its debt while maintaining a cash reserve of $4.5 million for operational expenses and growth initiatives?
**MWN-AI FAQ is based on asking OpenAI questions about FitLife Brands Inc. (NASDAQ: FTLF).
NASDAQ: FTLF
FTLF Trading
0.82% G/L:
$14.75 Last:
1,899 Volume:
$14.60 Open:
